Impax Laboratories Confirms Patent Challenge Relating to Fenoglide

Impax Laboratories Thursday confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc. in connection with its Fenoglide (fenofibrate) tablets, 40 and 120 mg.
Yahoo!